Document
IPR2017-01104, No. 2023-52 Exhibit - Exhibit 2023 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2023-52 Exhibit - Exhibit 2023 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1021-20 Exhibit - Ex 1021 US Application No 11553,339, Final Office Action mailed Dec 31, 2009 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1021-20 Exhibit - Ex 1021 US Application No 11553,339, Final Office Action mailed Dec 31, 2009 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1022-21 Exhibit - Ex 1022 US Application No 11553,339, Amendment After Final Action Under 37 CFR 1116 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1022-21 Exhibit - Ex 1022 US Application No 11553,339, Amendment After Final Action Under 37 CFR 1116 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2056-83 Exhibit - Exhibit 2056 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2056-83 Exhibit - Exhibit 2056 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2021-51 Exhibit - Exhibit 2021 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2021-51 Exhibit - Exhibit 2021 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2009-39 Exhibit - Exhibit 2009 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2009-39 Exhibit - Exhibit 2009 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2017-47 Exhibit - Exhibit 2017 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2017-47 Exhibit - Exhibit 2017 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1025-24 Exhibit - Ex 1025 FDA, Approved Drug Products with Therapeutic Equivalence Evaluations 33d ed 2013 Orange Book (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1025-24 Exhibit - Ex 1025 FDA, Approved Drug Products with Therapeutic Equivalence Evaluations 33d ed 2013 Orange Book (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1031-91 Exhibit - Ex 1031 Declaration of Kevin E Warner (P.T.A.B. Nov. 3, 2017)
Cite Document
IPR2017-01104, No. 1031-91 Exhibit - Ex 1031 Declaration of Kevin E Warner (P.T.A.B. Nov. 3, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2027-56 Exhibit - Exhibit 2027 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2027-56 Exhibit - Exhibit 2027 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2004-34 Exhibit - Exhibit 2004 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2004-34 Exhibit - Exhibit 2004 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2014-44 Exhibit - Exhibit 2014 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2014-44 Exhibit - Exhibit 2014 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2053-80 Exhibit - Exhibit 2053 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2053-80 Exhibit - Exhibit 2053 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2001-31 Exhibit - Exhibit 2001 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2001-31 Exhibit - Exhibit 2001 (P.T.A.B. Jul. 12, 2017)
+ More Snippets